Objective: Multiorgan dysfunction in asphyxiated newborns receiving therapeutic hypothermia achieved by either selective head cooling (SHC) or whole-body cooling (WBC) has not been well characterized. The beneficial effect of SHC in organs other than the brain may potentially be limited because unlike WBC, SHC aims to achieve effective brain cooling with lesssystemic hypothermia. However, the relative effects of SHC and WBC with currently available cooling protocols on multiorgan dysfunction are unknown.The aim of this study was to compare the multiorgan dysfunction in infants receiving therapeutic hypothermia induced by either SHC or WBC.
Introduction
Therapeutic hypothermia is neuroprotective in term newborns with hypoxic-ischemic encephalopathy (HIE), 1 but its effect on multiorgan or multisystem dysfunction, 2 a prevalent feature of the neonatal post-asphyxial syndrome, has not been well characterized. As the main pathogenetic processes of HIE and dysfunction of other organs are presumably similar after an hypoxic-ischemic insult, 3 therapeutic hypothermia achieved by either selective head cooling (SHC) or whole-body cooling (WBC) should also protect systemic organs other than the brain. Indeed, in a small study (as a part of the total body hypothermia (TOBY) efficacy trial), WBC was reported to improve multiorgan system dysfunction. 3 Although the proponents of SHC cite fewer systemic effects as a main advantage of this approach, the beneficial effect of SHC in organs other than the brain may potentially be limited because unlike WBC, SHC aims to achieve adequate cerebral cooling with only a small reduction in core temperature by cooling the surface of the head while actively warming the rest of the body. 4, 5 However, the relative effects of SHC and WBC, with currently available cooling protocols on multiorgan dysfunction in asphyxiated newborns, are unknown, 6, 7 As multiorgan system dysfunction may contribute significantly to an increased risk of morbidity, 8 this is an important clinical issue as the differential effects of WBC versus SHC on organs other than the brain may influence the choice of the mode of cooling.
We carried out this observational study to characterize multiorgan dysfunction in asphyxiated infants receiving therapeutic hypothermia, and to examine whether important components of multiorgan system dysfunction during the period of therapeutic hypothermia differ between WBC and SHC.
Patients and methods
The University of Michigan has used both SHC and WBC in infants of X36 weeks gestation with significant HIE. The entry and exclusion criteria for recruitment of the infants have been reported earlier. 9 Clinical monitoring and treatment during cooling, whether SHC or WBC, were carried out according to the cool cap and NICHD WBC protocols. 6, 7 The multiorgan dysfunction in infants during 72 h of therapeutic hypothermia, achieved by either SHC or WBC, was assessed by undertaking clinical monitoring, physiological recordings and laboratory tests at predefined time points, as originally described in the cool cap protocol. 6 The severity of pulmonary, hepatic and renal dysfunction, and coagulopathy and electrolyte disturbances were assessed with serial measurements of ventilatory parameters (peak inspiratory pressure, positive and expiratory pressure and inspired oxygen fraction); simultaneous A-aDO 2 and PaCO 2 ; serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT); serum creatinine and urine output; prothrombin time (PT) and partial thromboplastin time (PTT); and international normalized ratio (INR), platelet count, serum sodium, potassium and calcium before the start of cooling (baseline), and at specific time intervals (24, 48 and 72 h) throughout cooling, as originally specified in the cool cap trial. 6 The important components of multiorgan dysfunction were defined as follows: pulmonary dysfunction (that is, the presence of clinical respiratory distress along with the need for ventilatory support with positive pressure and supplemental oxygen); cardiac dysfunction (that is, mean blood pressure <40 mm of Hg treated with vasopressors for >24 h); renal dysfunction (that is, oliguria with urine output <0.5 ml kg -1 h -1 for >24 h after birth, or rising serum creatinine with maximum serum creatinine >0.9 mg dl -1 ); coagulopathy (that is, abnormal clotting studies consistent with disseminated intravascular coagulation or hepatic coagulopathy, with or without associated clinical bleeding); bone marrow suppression (that is, platelet count <100 000 ml -1 ); hyponatremia (that is, serum sodium <130 mmol l -1 ); hypokalemia (that is serum potassium <3.5 mmol l -1 ); and hypocalcemia (serum calcium <8 mg d l -1 ), similar to the definitions used earlier. 2, 6, 7 To monitor for potential adverse or beneficial effects of a specific method of hypothermia, data collected during the 72 h period of cooling also included the need for vasopressors for >24 h, fresh frozen plasma (FFP) and platelet transfusions, peritoneal dialysis, inhaled nitric oxide (iNO) or extracorporeal membrane oxygenation (ECMO) for persistent pulmonary hypertension (PPHN) and the rate of successful extubation after the determining of the readiness for extubation by the minute ventilation test. 10 Mechanical ventilator settings were adjusted to maintain pH >7.25 and PaCO 2 >30 torr; vasopressors were used to maintain a mean arterial blood pressure >40 mm Hg; and platelets and FFP transfusions were given to maintain platelet counts >50 000 per ml and INR <2, respectively. Serum sodium was to be maintained >130 mEq l -1 , and serum potassium >3.5 mEq l -1 . Data collection for this present observation has been detailed elsewhere. 9 Cooling for the infants was started after written informed consent from a parent, and the study was approved by the Institutional Review Board.
Statistical analyses
Statistical analyses were carried out using Student's t-test or the Mann-Whitney test to compare the SHC and WBC groups, and categorical variables were analyzed using Fisher's exact test or chi-square analysis, as appropriate. Two-sided P-values are reported throughout. Significance was deemed to be Pp0.05.
Results
Multiorgan dysfunction outcomes were evaluable in 59 of 63 infants (WBC-28, SHC-31) who received cooling for moderate (stage 2) or severe (stage 3) HIE between December 2003 and October 2007. Of the remaining four infants who were initially started on SHC, two were switched to WBC because of malfunction of the cool cap device, one died soon after the start of cooling, and one had severe non-immune hydrops fetalis and was excluded from analysis.
The neonatal and obstetrical characteristics of the 59 infants are shown in Table 1 . The demographic characteristics, acute intrapartum sentinel event (if known) and clinical and laboratory evidence of an intrapartum hypoxic-ischemic event (apgar scores at 5 and 10 min, clinical seizures before admission, pH and base deficit within 60 min of birth and stages of encephalopathy) at the initiation of cooling for the 28 WBC and 31 SHC infants have been reported and were similar between the two groups. 9 Of the 59 cooled infants (WBC-28, SHC-31), all but two infants from the SHC group required mechanical ventilation for varying duration and nine infants (WBC-5, SHC-4) developed PPHN during cooling ( Table 2) . As reported earlier, 9 the incidence of PPHN was similar in both the WBC and SHC groups and equivalent numbers of infants from both groups were extubated after an improvement in respiratory status while still being cooled (Table 2) . Table 2 shows the comparison of cooling-associated multiorgan dysfunction during 72 h of cooling between the WBC and SHC groups. Coagulopathy (with and without clinical bleeding) and thrombocytopenia treated with FFP and platelet transfusion were similar, and similar numbers of infants from both groups were treated with vasopressors for >24 h. The incidence of oliguria (urine output <0.5 ml kg -1 h -1 for >24 h after birth), rising serum creatinine (with maximum serum creatinine >0.9 mg dl -1 ), need for peritoneal dialysis, hyponatremia, hypokalemia and hypocalcemia was also similar (Table 2) .
Serial measurements of ALT and AST were carried out on all 28 WBC infants and on 25 of the 31 SHC infants. Of the remaining six SHC infants, one died before repeat serum transaminases could be obtained and five had normal initial values not requiring follow-up.
Among the 53 infants (WBC-28, SHC-25) evaluated for hepatic dysfunction, serum transaminases (both ALT and AST) worsened for varying time during the period of cooling, with significantly higher maximum values during 72 h of cooling compared with the values obtained at the initiation (baseline) of cooling (Table 3) . By the end of cooling, both transaminases showed significant improvement; and the decline was steeper for AST, with the 72 h AST significantly lower than that at baseline (Table 4) . Table 5 shows the comparison of laboratory parameters between the WBC and SHC groups. Serum transaminases, PT, PTT, INR, platelet counts, serum creatinine, serum sodium, serum potassium and serum calcium were similar between the groups at the initiation of cooling. These laboratory parameters to assess the differential effect of WBC versus SHC on multiorgan dysfunction during 72 h of cooling did not differ with the method of cooling, as the maximum serum transaminases (both ALT and AST), maximum coagulation profile (PT, PTT and INR), maximum serum creatinine, lowest platelet count, lowest serum electrolytes (sodium, potassium and calcium) and maximum serum potassium during cooling were also similar between the two groups ( Table 5 ).
Discussion
The postulated mechanisms for hypothermic neuroprotection are non-specific and include reduction in cerebral energy metabolism, suppression of programmed cell death, suppression of posthypoxic-ischemic accumulation of cytotoxins (for example, oxygen free radicals and nitric oxide), preservation of endogenous antioxidants, protection against lipid peroxidation and reduction of intracellular acidosis. [11] [12] [13] In theory, the beneficial effect of therapeutic hypothermia achieved by either SHC or WBC should extend beyond the brain to include other organs commonly affected during an hypoxic-ischemic insult. 3 Indeed, in the cool cap trial, attenuation of hepatic dysfunction was more common in the cooled than in the non-cooled infants and similar attenuation in hepatic and renal dysfunctions in the cooled group was also observed in a small group of infants enrolled for WBC as a part of the TOBY efficacy trial. 3, 6 The NICHD trial did not show any difference in multiorgan dysfunction between WBC and non-cooled infants, possibly because the infants in this trial had milder 
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Effects of therapeutic hypothermia S Sarkar et al asphyxia and lower overall incidence of multiorgan dysfunction compared with that in the infants in other trials. 3, 7 In contrast, in the South Carolina WBC trial, in which cooling was more profound with a target core temperature of 32.5-33.5 1C, and in which late preterm infants (X35 weeks' gestational age) were also cooled, hematuria, thrombocytopenia and the use of FFP and vasopressors were more common in the hypothermic compared with those in the control group.
14 Multiorgan dysfunction has also been analyzed in one of the systematic reviews of all the earlier SHC and WBC trials. 15 However, the relative effect of the two modes of cooling on multiorgan system dysfunction has not been compared earlier. Our observational study, although non-randomized and from a single center, represents the largest number of asphyxiated newborns studied to examine the differential effect of WBC versus SHC on multiorgan system dysfunction. 6, 7 Similar to other large cooling trials, 6, 7, 14 the laboratory parameters chosen to assess multiorgan dysfunction reported in our infants actually reflect the net effect of expected postnatal fluctuations and ongoing corrections aimed at normalizing these parameters, in addition to the effects of cooling itself on these organs. Abbreviations: CI, confidence interval; ECMO, extracorporeal membrane oxygenation; FFP, fresh frozen plasma; OR, odds ratio; PPHN, persistent pulmonary hypertension of the newborn; SHC, selective head cooling; WBC, whole body cooling. Data are number of patients (%). a Data not included for one WBC infant receiving ECMO during cooling. Effects of therapeutic hypothermia S Sarkar et al 
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We assessed the relative effects of WBC and SHC on most of the clinically important components of multiorgan system dysfunction commonly seen during the three earlier large randomized cooling trials, 6, 7, 14 and in one systematic review of five of the earlier cooling trials. 15 The severity of hypoxic-ischemic insult was similar between the WBC and SHC groups as clinical and laboratory evidence of an intrapartum hypoxic-ischemia was similar at the initiation of cooling. Furthermore, the laboratory values to assess multiorgan dysfunction were also similar at the initiation of cooling. This observational study suggests that the important components of multiorgan system dysfunction commonly seen in asphyxiated newborns during cooling remain similar for both WBC and SHC.
Our data showing no differential effect of the cooling method on multiorgan dysfunction are similar to the recently reported animal data, which found no difference between the two cooling methods in any of the biochemical or histopathological variables investigated. 16 Either method induces only mild-to-moderate hypothermia, with target rectal temperatures of 34.5 1C for SHC and target esophageal temperatures of 33.5 1C for WBC. 6, 7 We speculate that currently available cool cap and NICHD WBC protocols do not lead to hypothermia profound enough to adversely affect multiorgan function, and the target core temperatures maintained during SHC and WBC are probably not significantly different to produce hypothesized differential, and clinically significant, protective or adverse effects.
We conclude that the important components of multiorgan system dysfunction in asphyxiated newborns during cooling remain similar for both WBC and SHC. Concerns regarding a differential effect of WBC versus SHC on multiorgan dysfunction other than that of the brain should not be a consideration in selecting a method to produce therapeutic hypothermia.
